Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support
| Image |  |
|---|---|
| Description | scientific article published on 28 September 2015 |
| Author/s |
author: Dirk Rades |
| Publication date | September 28, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |